Keating Investment Counselors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.17M | Sell |
186,801
-2,005
| -1% | -$77K | 2.17% | 8 |
|
|
2025
Q1 | $7.31M | Buy |
188,806
+25,201
| +15% | +$976K | 2.21% | 7 |
|
|
2024
Q4 | $5.53M | Buy |
+163,605
| New | +$5.53M | 1.73% | 15 |
|
|
2023
Q1 | – | Sell |
-197,918
| Closed | -$6.95M | – | 82 |
|
|
2022
Q4 | $6.95M | Buy |
197,918
+56,742
| +40% | +$1.99M | 2.72% | 14 |
|
|
2022
Q3 | $4.16M | Buy |
141,176
+420
| +0.3% | +$12.4K | 1.86% | 19 |
|
|
2022
Q2 | $7.66M | Sell |
140,756
-706
| -0.5% | -$38.4K | 3.23% | 9 |
|
|
2022
Q1 | $7.7M | Hold |
141,462
| – | – | 3.3% | 10 |
|
|
2021
Q4 | $7.8M | Buy |
141,462
+106
| +0.1% | +$5.84K | 3.45% | 8 |
|
|
2021
Q3 | $6.75M | Buy |
141,356
+1,608
| +1% | +$76.8K | 3.16% | 11 |
|
|
2021
Q2 | $6.96M | Buy |
+139,748
| New | +$6.96M | 3.19% | 10 |
|